Carlo de Notaristefani
2017
Compensation breakdown
| Option Awards | $866,688 |
|---|---|
| Salary | $836,400 |
| Stock Awards | $2,569,720 |
| Other | $189,551 |
| Total | $4,462,359 |
de Notaristefani received $2.6M in stock awards, accounting for 58% of the total pay in 2017.
de Notaristefani also received $866.7K in option awards, $836.4K in salary and $189.6K in other compensation.
Rankings
In 2017, Carlo de Notaristefani's compensation ranked 2,219th out of 14,666 executives tracked by ExecPay. In other words, de Notaristefani earned more than 84.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,219 out of 14,666 | 85th |
Division Manufacturing | 767 out of 5,772 | 87th |
Major group Chemicals And Allied Products | 209 out of 2,075 | 90th |
Industry group Drugs | 158 out of 1,731 | 91st |
Industry Pharmaceutical Preparations | 123 out of 1,333 | 91st |
de Notaristefani's colleagues
We found nine more compensation records of executives who worked with Carlo de Notaristefani at Teva Pharmaceutical Industries in 2017.
2017
Kåre Schultz
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Yitzhak Peterburg
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Rob Koremans
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Michael Hayden
Teva Pharmaceutical Industries
Chief Scientific Officer
2017
Eyal Desheh
Teva Pharmaceutical Industries
Chief Financial Officer
2017
Hafrun Fridriksdottir
Teva Pharmaceutical Industries
Executive Vice President, Global Research and Development
2017
Erez Vigodman
Teva Pharmaceutical Industries
Chief Executive Officer
2017
Mark Sabag
Teva Pharmaceutical Industries
Executive Vice President, Global Human Resources
2017
Michael McClellan
Teva Pharmaceutical Industries